Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04194541 · ClinicalTrials.gov registry record · NA
Wound Dressings for Hidradenitis Suppurativa
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT04194541: Completed NA study, sponsored by University of Miami.
NCT04194541 is a NA study that has completed, run by University of Miami. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04194541, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The primary purpose of this research is to determine how the types of wound dressings affect quality of life for people with Hidradenitis Suppurativa (HS).
Primary Outcome
Participant quality of life as measured via DLQI. DLQI has a total score ranging from 0-30 with the higher score indicating more impairment on the participant's quality of life.
Interventions
- DEVICE Cutimed Sorbact Hydroactive B wound dressing
- DEVICE Cutimed Siltect wound dressing
- DEVICE Sorbion Sana multi-star wound dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2020-01-28 |
| Est. Completion | 2021-03-08 |
| Phase | NA |
What the finished NCT04194541 record still lists
NCT04194541 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Cutimed Sorbact Hydroactive B wound dressing is the first listed.
NCT04194541 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04194541 about?
NCT04194541 is a clinical study titled "Wound Dressings for Hidradenitis Suppurativa". The primary purpose of this research is to determine how the types of wound dressings affect quality of life for people with Hidradenitis Suppurativa (HS).
What is the current status of trial NCT04194541?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2020-01-28. Estimated completion is 2021-03-08.
What interventions are being tested in trial NCT04194541?
The interventions under investigation include: Cutimed Sorbact Hydroactive B wound dressing (DEVICE), Cutimed Siltect wound dressing (DEVICE), Sorbion Sana multi-star wound dressing (DEVICE).
Who is sponsoring clinical trial NCT04194541?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04194541's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI